Identification and Therapeutic Intervention of Co-Activated ALK, FGFR2 and EphA5 Kinases in Hepatocellular Carcinoma

Hepatology - United States
doi 10.1002/hep.29792
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Somatostatin in Hepatocellular Carcinoma: Experimental and Therapeutic Implications

Hepatoma Research
2018English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Diagnostic and Therapeutic Implications of Novel Peptides in Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

CDK8 and CDK19 Kinases Have Non-Redundant Oncogenic Functions in Hepatocellular Carcinoma

2019English

Predictors of Surgical Intervention for Hepatocellular Carcinoma

Archives of Surgery
2011English

Microtubule-Targeting Agents in Oncology and Therapeutic Potential in Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

FGFR2 Alterations in Endometrial Carcinoma

Modern Pathology
Forensic MedicinePathology
2011English

Identification of the Typical miRNAs and Target Genes in Hepatocellular Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

ALK in Neuroblastoma: Biological and Therapeutic Implications

Cancers
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy